MDNAF · Medicenna Therapeutics Corp. · Documents
Market Cap
$28.15M
Shares
92.30M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2024-05-13 | — | |
| 6-K | 2024-04-30 | — | |
| 6-K | 2024-04-26 | — | |
| 6-K | 2024-04-25 | 2024-04-24 | |
| 6-K | 2024-04-10 | 2024-04-09 | |
| 6-K | 2024-04-09 | — | |
| 6-K | 2024-04-04 | — | |
| 6-K | 2024-03-06 | — | |
| 6-K | 2024-02-14 | 2023-12-31 | |
| 6-K | 2024-02-13 | — | |
| 6-K | 2024-01-24 | — | |
| 6-K | 2024-01-16 | 2024-01-12 | |
| 6-K | 2024-01-09 | — | |
| 6-K | 2024-01-05 | — | |
| 6-K | 2023-12-22 | 2023-12-21 | |
| 6-K | 2023-12-22 | 2023-12-19 | |
| 6-K | 2023-11-21 | 2023-11-17 | |
| 6-K | 2023-11-14 | 2023-09-30 | |
| 6-K | 2023-11-08 | — | |
| 6-K | 2023-10-25 | — | |
| 6-K | 2023-10-24 | — | |
| 6-K | 2023-10-10 | — | |
| 6-K | 2023-10-03 | — | |
| 6-K | 2023-09-28 | — | |
| 6-K | 2023-09-28 | — | |
| 6-K | 2023-09-06 | — | |
| 6-K | 2023-08-28 | 2023-09-28 | |
| 6-K | 2023-08-28 | — | |
| 6-K | 2023-08-14 | — | |
| 6-K | 2023-08-09 | — | |
| 6-K | 2023-08-08 | — | |
| 6-K | 2023-08-04 | — | |
| 6-K | 2023-08-01 | — | |
| 6-K | 2023-07-28 | 2023-06-30 | |
| 6-K | 2023-07-25 | — | |
| 6-K | 2023-07-06 | 2023-07-05 | |
| 6-K | 2023-06-27 | — | |
| 20-F | 2023-06-27 | 2023-03-31 | |
| 6-K | 2023-04-27 | — | |
| 6-K | 2023-04-18 | — | |
| 6-K | 2023-04-17 | — | |
| 6-K | 2023-03-30 | — | |
| 6-K | 2023-03-15 | — | |
| 6-K | 2023-03-02 | — | |
| 6-K | 2023-02-17 | — | |
| 6-K | 2023-02-07 | 2022-12-31 | |
| 6-K | 2023-01-31 | — | |
| 6-K | 2023-01-26 | — | |
| 6-K | 2023-01-05 | — | |
| 6-K | 2022-11-10 | — |
Showing 1–50 of 143 filings